Whether RECIST and mRECIST criteria were used for assessment, HVTT shows a higher ORR in all subgroups, with a significant difference, except for the subgroups of female, HBV negative, Child-Pugh B, cirrhosis, single tumor, without previous anti-tumor treatment, which showed a tendency toward statistical significance ( Tables S5 and S6 ).
← all excerpts
Treatment response and prediction model of radiotherapy for hepatocellular carcinoma with macrovascular tumor thrombus: a multicenter retrospective study.
1
—
—